Financings in Brief: Urologix
This article was originally published in The Gray Sheet
Executive Summary
Urologix: Underwriters for the firm's initial public offering exercise over-allotment option to buy an additional 405,000 shares for $14 each. The company closed June 4 on its initial, 2.7 mil. share offering ("The Gray Sheet" June 3, p. 12)...